Abstract-Since the initial reports that renal cytochrome P450 (CYP) enzymes can metabolize arachidonic acid to substances which affect arterial tone, it has become increasingly clear that CYP enzymes expressed within the cardiovascular system play a crucial role in the modulation of vascular homeostasis. There is strong evidence suggesting that the activation of a CYP epoxygenase in endothelial cells is an essential step in nitric oxide and prostacyclinindependent vasodilatation of several vascular beds, particularly in the heart and kidney. A smooth muscle CYP -hydroxylase, on the other hand, generates a vasoconstrictor eicosanoid that is central to the myogenic response. Moreover, CYP epoxygenase and -hydroxylase products, as well as CYP-derived reactive oxygen species, are intracellular signal transduction molecules involved in several signaling cascades affecting numerous cellular processes, including vascular cell proliferation and angiogenesis. This review summarizes the vascular effects of epoxyeicosatrienoic acids and 20-hydroxyeicosatetraenoic acid, both of which are CYP-derived metabolites of arachidonic acid, endogenously generated within endothelial and vascular smooth muscle cells. Although the link between CYP expression/activity and cardiovascular disease is currently tentative, the evidence being accumulated to suggest that CYP pathways are altered in animal models of hypertension and atherosclerosis can no longer be ignored. The development of selective pharmacological tools is, however, a prerequisite for the analysis of the involvement of specific CYP isoforms in the regulation of vascular homeostasis in human subjects. Key Words: endothelial dysfunction Ⅲ endothelium-derived hyperpolarizing factor Ⅲ epoxyeicosatrienoic acids Ⅲ free radicals Ⅲ 20-hydroxyeicosatetraenoic acid C ytochrome P450 (CYP) enzymes are membrane-bound, heme-containing terminal oxidases in a multienzyme system that also includes a FAD/FMN-containing NADPHcytochrome P450 reductase and cytochrome b 5 . CYP enzymes oxidize, peroxidize, and/or reduce cholesterol, vitamins, steroids, xenobiotics, and numerous pharmacological substances in an oxygen-and NADPH-dependent manner. Some CYP isoforms are fairly specific in their choice of substrates but many, particularly those in the endoplasmic reticulum, catalyze a large number of chemical reactions and can use an almost unlimited number of biologically occurring and synthetic compounds. Because many CYP isozymes are also capable of metabolizing arachidonic acid to biologically active products, 1,2 CYP enzymes are often described as the third pathway of arachidonic acid metabolism (ie, in addition to cyclooxygenases and lipoxygenases), although they also oxidize other endogenous lipids such as retinoic and linoleic acid. CYP products derived from substrates other than arachidonic acid also elicit physiological responses. For example, the epoxygenase CYP 2J2 can generate epoxyeicosatrienoic acids (EETs) from arachidonic acid and epoxyeicosaquatraenoic acids from eicosapentaenoic ac...